Kempharm Stock Filter Stocks by Fundamentals
KMPHDelisted Stock | USD 5.81 0.02 0.34% |
KemPharm fundamentals help investors to digest information that contributes to KemPharm's financial success or failures. It also enables traders to predict the movement of KemPharm Stock. The fundamental analysis module provides a way to measure KemPharm's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to KemPharm stock.
KemPharm |
Did you try this?
Run AI Portfolio Architect Now
AI Portfolio ArchitectUse AI to generate optimal portfolios and find profitable investment opportunities |
All Next | Launch Module |
KemPharm Fundamentals
Return On Equity | -0.31 | |||
Return On Asset | -0.0897 | |||
Operating Margin | (1.72) % | |||
Current Valuation | 97.06 M | |||
Shares Outstanding | 34.5 M | |||
Shares Owned By Insiders | 10.29 % | |||
Shares Owned By Institutions | 17.68 % | |||
Number Of Shares Shorted | 1.37 M | |||
Price To Earning | 17.87 X | |||
Price To Book | 1.69 X | |||
Price To Sales | 14.16 X | |||
Revenue | 28.65 M | |||
Gross Profit | 26.59 M | |||
EBITDA | (8.29 M) | |||
Net Income | (8.55 M) | |||
Cash And Equivalents | 80.98 M | |||
Cash Per Share | 2.35 X | |||
Total Debt | 16.16 M | |||
Debt To Equity | 0.16 % | |||
Current Ratio | 12.21 X | |||
Book Value Per Share | 2.72 X | |||
Cash Flow From Operations | 10.44 M | |||
Short Ratio | 5.87 X | |||
Earnings Per Share | (0.91) X | |||
Target Price | 22.33 | |||
Number Of Employees | 24 | |||
Beta | 2.16 | |||
Market Capitalization | 200.65 M | |||
Total Asset | 132.94 M | |||
Retained Earnings | (252.18 M) | |||
Working Capital | 45.74 M | |||
Current Asset | 54.08 M | |||
Current Liabilities | 8.34 M | |||
Z Score | 5.8 | |||
Net Asset | 132.94 M |
About KemPharm Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze KemPharm's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of KemPharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of KemPharm based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company was incorporated in 2006 and is headquartered in Celebration, Florida. Kempharm operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 24 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards KemPharm in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, KemPharm's short interest history, or implied volatility extrapolated from KemPharm options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in KemPharm Stock
If you are still planning to invest in KemPharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the KemPharm's history and understand the potential risks before investing.
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |